Top Markets
Coin of the day
Proteome Sciences plc Proteome Sciences plc

Proteome Sciences plc

PRM
株式のランク #40896
Proteome Sciences plc provides contract research services for the... Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
株価
$0.02449263
時価総額
$70.76K
変化(1日)
0.00%
変化(1年)
-39.87%
GB
取引 Proteome Sciences plc (PRM)

カテゴリー

Proteome Sciences plc(PRM)の配当利回りの履歴
Proteome Sciences plc(銘柄コード: PRM)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Proteome Sciences plc(PRM)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)